Viewing Study NCT03224702


Ignite Creation Date: 2025-12-25 @ 3:44 AM
Ignite Modification Date: 2026-02-26 @ 2:17 AM
Study NCT ID: NCT03224702
Status: COMPLETED
Last Update Posted: 2019-05-02
First Post: 2017-07-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: First-in-Human Trial of Anti-ADAMTS-5 Nanobody in Healthy Volunteers
Sponsor: Merck KGaA, Darmstadt, Germany
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None M6495 View
None anti-A disintegrin and metalloproteinase with thrombospondin motifs-5 nanobody View
None Osteoarthritis View